ロード中...
Insulin Degludec Aspart: The First Co-formulation of Insulin Analogues
Insulin degludec/insulin aspart (IDegAsp) is the first soluble co-formulation which combines two insulin analogues, and provides effective basal and prandial glycemic coverage. It has been assessed as basal insulin in type 2 diabetes mellitus (T2DM), and as part of basal-bolus regime in both type 1...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4065296/ https://ncbi.nlm.nih.gov/pubmed/24828136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-014-0067-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|